/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

M

Michael V. Seiden

Emergency University(US)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

242

Papers

14.1K

Citations

56

h-index

127

i10-index

Michael V. Seiden is an academic researcher from Emergency University. The author has contributed to research in topics: Ovarian cancer diagnosis and treatment & Cancer Genomics and Diagnostics & Intraperitoneal and Appendiceal Malignancies. The author has an h-index of 56, co-authored 206 publications.

Research Topics

Ovarian cancer diagnosis and treatment Cancer Genomics and Diagnostics Intraperitoneal and Appendiceal Malignancies Endometrial and Cervical Cancer Treatments Cancer Treatment and Pharmacology

Papers by this author

works

Phase III Trial of Intraperitoneal Therapy With Yttrium-90–Labeled HMFG1 Murine Monoclonal Antibody in Patients With Epithelial Ovarian Cancer After a Surgically Defined Complete Remission

2006 · Journal of Clinical Oncology · 190 citations

https://doi.org/10.1200/jco.2005.02.5973

René H.M. Verheijen Leon F.A.G. Massuger Benedict B. Benigno Agamemnon A. Epenetos

The Clinical Utility of Liposomal Doxorubicin in Recurrent Ovarian Cancer

2001 · Gynecologic Oncology · 112 citations

https://doi.org/10.1006/gyno.2000.5980

Susana M. Campos Richard T. Penson Aisha Mays Ross S. Berkowitz

A Phase II Study of the MDR Inhibitor Biricodar (INCEL, VX-710) and Paclitaxel in Women with Advanced Ovarian Cancer Refractory to Paclitaxel Therapy

2002 · Gynecologic Oncology · 98 citations

https://doi.org/10.1006/gyno.2002.6762

Michael V. Seiden Kenneth D. Swenerton Ursula A. Matulonis Susan Campos

Phase II study of intraperitoneal recombinant interleukin-12 (rhIL-12) in patients with peritoneal carcinomatosis (residual disease < 1 cm) associated with ovarian cancer or primary peritoneal carcinoma

2007 · Journal of Translational Medicine · 79 citations

https://doi.org/10.1186/1479-5876-5-66

Renato Lenzi Robert P. Edwards Carl H. June Michael V. Seiden

Metastatic Mucinous Ovarian Cancer and Treatment Decisions Based on Histology and Molecular Markers Rather Than the Primary Location

2012 · Journal of the National Comprehensive Cancer Network · 27 citations

https://doi.org/10.6004/jnccn.2012.0113

Angela Jain Paula D. Ryan Michael V. Seiden

A phase I clinical trial of continual alternating etoposide and topotecan in refractory solid tumours

2005 · British Journal of Cancer · 5 citations

https://doi.org/10.1038/sj.bjc.6602671

Richard T. Penson Michael V. Seiden Ursula A. Matulonis Leonard J. Appleman

Research topics

topics

Ovarian cancer diagnosis and treatment

Cancer Genomics and Diagnostics

Intraperitoneal and Appendiceal Malignancies

Endometrial and Cervical Cancer Treatments

Cancer Treatment and Pharmacology

Chat about Author

Papers

Chat

Click to start Chat